Eylward Susan's Form 4 filing
Imunon, Inc.IMNN · filed Jul 21, 2026
- Accession no.
- 0001437749-26-023948
- Filed
- Jul 21, 2026, 4:15 PM ET
- Trade date
- Jul 17-20, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $3.83K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eylward SusanCIK 0002039135 | Officer (General Counsel and Corp Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | AGrant or awardAcquired | +2,150 | $1.83 | +$3,934.5 | 5,046 | Direct | |
| Jul 20, 2026 | Common Stock | SSaleDisposed | −2,150 | $1.78F2 | −$3,830.44 | 2,896 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Reflects a weighted average sale price of $1.7816 per share, at prices ranging from $1.76 to $1.79 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.